FAST NEWS: Ascletis Pharma’s Monkeypox Drug Gets IND Approval
The latest: Ascletis Pharma Inc. (1672.HK) announced on Thursday that the China National Medical Products Administration (NMPA) has approved an Investigational New Drug (IND) application for its oral viral polymerase…
FAST NEWS: Ascletis Covid, Monkeypox Virus Inhibitor Gets U.S. Patent
The latest: Ascletis Pharma Inc. (1672.HK) said on Monday the U.S. Patent and Trademark Office (USPTO) has granted it a patent for its oral viral polymerase inhibitor ASC10 and its…
